omega-n-methylarginine has been researched along with ns 309 in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (ns 309) | Trials (ns 309) | Recent Studies (post-2010) (ns 309) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 56 | 1 | 30 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellien, J; Favre, J; Gao, J; Iacob, M; Joannidès, R; Richard, V; Thuillez, C | 1 |
1 trial(s) available for omega-n-methylarginine and ns 309
Article | Year |
---|---|
Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans.
Topics: Adult; Animals; Benzimidazoles; Biological Factors; Blood Pressure; Elasticity; Endothelium, Vascular; Enzyme Inhibitors; Fluconazole; Hot Temperature; Humans; Hypertension; Indoles; Male; Mice; Mice, Inbred Strains; Nitric Oxide; omega-N-Methylarginine; Oximes; Potassium Channel Blockers; Radial Artery; Regional Blood Flow; Tetraethylammonium; Vasodilation; Young Adult | 2010 |